Celanese (CE) Q4 2006 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2006 earnings summary
10 Nov, 2026Executive summary
FY 2006 net sales rose 10.3% to $6.656B; operating profit increased 30.3% to $747M and net earnings reached $406M, supported by pricing, volume gains, productivity and lower one-time charges.
Q4 net sales were $1.656B, operating profit $185M, net earnings $77M and diluted EPS $0.45.
Financial highlights
FY net sales grew 10.3% YoY; pricing contributed 4% and volumes 1%, with acquisitions and currency also lifting sales.
Gross margin was 21.7% versus 21.6% in 2005; higher pricing and volumes largely offset raw material and energy cost increases.
Operating profit was $747M versus $573M; adjusted for 2005 debt-refinancing premiums and accelerated financing-cost amortization, FY 2006 interest expense fell to $294M from $387M.
Net earnings were $406M versus $277M; continuing-operations diluted EPS was $2.37 versus $1.66.
Operating cash flow was $751M; cash and equivalents ended 2006 at $791M, up $401M YoY.
Outlook and guidance
2007 capital expenditures expected at $280M, versus $252M in 2006; spend includes growth capacity, equipment replacements, cost reduction and environmental projects.
Nanjing integrated chemical complex, including a 600,000-metric-ton acetic acid plant, was targeted to begin commercial sales in 2007.
Acetate tow market expected to grow 1%–2% annually; technical polymers demand expected to grow 5%–6% annually.
Liquidity resources expected to cover requirements, including debt service, for the remainder of 2007; outlook remained dependent on cash generation and credit availability.
Latest events from Celanese
- Sales and operating profit grew, but financing costs and restructuring drove a $253 million loss.CE
Q4 2004 - Pricing and productivity lifted FY 2005 profit, but leverage and input-cost risks persisted.CE
Q4 2005 - Pricing and currency lifted sales 12%, while outages, costs and refinancing weighed on results.CE
Q4 2007 - Recession cut earnings, but cash improved and recovery was expected in 2010.CE
Q4 2009 - Recovery lifted sales and operating profit; 2011 growth was expected across all segments.CE
Q4 2010 - FY11 earnings grew on pricing and mix, while major capacity and ethanol investments set up the next growth phase.CE
Q4 2011 - Acetyl pricing and currency dragged FY12 results; 12%–14% earnings growth targeted for FY13.CE
Q4 2012 - A $742 million relocation gain drove record reported profit amid mixed segment trends.CE
Q4 2013 - Sales and adjusted EPS advanced as record cash flow funded growth and shareholder returns.CE
Q4 2014